Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide

Eur J Haematol. 2014 Feb;92(2):179-80. doi: 10.1111/ejh.12233. Epub 2013 Dec 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Anemia, Refractory / diagnosis
  • Anemia, Refractory / drug therapy*
  • Anemia, Refractory / pathology*
  • Bone Marrow / pathology
  • Erythrocytes, Abnormal / pathology*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lenalidomide
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Thrombocytosis / pathology*
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Thalidomide
  • Lenalidomide